NATALIE ROBY: Open Payments
NPI 1831273929 · ONTARIO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 119 payments from 25 companies in 2025. Trend: 2023 $1,365 · 2024 $1,694 · 2025 $2,079
Food & beverage: $2,079
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $470 |
| AstraZeneca Pharmaceuticals LP | 6 | $168 |
| Novo Nordisk Inc | 10 | $167 |
| Lilly USA, LLC | 11 | $153 |
| Amgen Inc. | 11 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Axsome Therapeutics, Inc. | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| PFIZER INC. | 4 | $78 |
Products named: UBRELVY, VRAYLAR, MOUNJARO, CAPLYTA, AIRSUPRA, Wegovy, Auvelity, Kerendia.
Industry payments across OH — which companies pay providers there.
